Company / Total Assets
Esperion Therapeutics, Inc. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$465.9M
FY2025
5-year range
$205.8M / $465.9M
FY2021-FY2025
Trend
+35.5%
vs FY2024
Sector context
#146 of 214
Health Care
What the data says
At $466M, Esperion Therapeutics, Inc.'s total assets ranks #146 of 214 in the Health Care sector. Total Assets has fluctuated over the past 10 years, ranging from $143M in FY2018 to $466M in FY2025.
Based on SEC 10-K filings.
$466M in FY2025 with a 5-year CAGR of +5.7%.
Improved from $206M to $466M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +23.4%
- 5-Year CAGR
- +5.7%
- 10-Year CAGR
- -
Sector benchmark
#146 of 214 in Health CareTop 68% of 214This company $465.9M Sector average $7.5B
▼
-93.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +5.7%, indicating consistent growth.
- In FY2025, total assets increased 35.5% year-over-year.
- Ranks #146 out of 214 companies in the Health Care sector.
- Lowest total assets in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -1.60 (distress zone, below 1.8 threshold)
- Negative profit margin: -15.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $465.9M | +35.5% |
| FY2024 | $343.8M | +67.1% |
| FY2023 | $205.8M | -17.0% |
| FY2022 | $247.9M | -35.0% |
| FY2021 | $381.6M | +8.0% |
| FY2020 | $353.3M | +64.7% |
| FY2019 | $214.4M | +49.5% |
| FY2018 | $143.5M | -48.4% |
| FY2017 | $277.8M | +13.3% |
| FY2016 | $245.2M | -17.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026